Christopher Desutter, MD
Foot and Ankle Surgery · Boise, IDNPI 1104473883
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,919 of the $3,893 with a category attached, or 75.0%. 12 manufacturers reported payments, led by Stryker at 45.6% of the total. Reporting peaked in 2019 at $1,430 and has fallen 99.0% since, to $15 in 2025.
Across 55 payments — averaging $70.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Arthrex$1K
- Smith+Nephew$250
- Bioventus LLC$150
- Anika Therapeutics, Inc.$137
- Goode Surgical Inc$129
- plus $390 from 6 others
What the payments were for
- Travel & lodging$97425%
- Food & beverage$2,91975%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 22 | $1,777 |
| Arthrex | 9 | $1,059 |
| Smith+Nephew | 2 | $250 |
| Bioventus LLC | 8 | $150 |
| Anika Therapeutics, Inc. | 1 | $137 |
| Goode Surgical Inc | 3 | $129 |
| Acell, Inc. | 1 | $121 |
| Steelhead Surgical Inc | 3 | $121 |
| Avanos Medical | 3 | $73 |
| Ossio Inc | 1 | $32 |
| Arthrosurface Incorporated | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$714
- TRIGEN InterTAN$250
- EVOS$144
- MAVERICK$144
- ORTHOLOC 3DI CROSSCHECK$142
- Tactoset Hip Registry Place Holder$137
- PROPHECY$129
- ACCULIF$120
- VARIAX$113
How this compares
$3,893 in reported general payments places this provider in the 55th percentile of 49 foot and ankle surgery providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 60 | $413 |
| Ondansetron OdtOndansetron | 27 | $323 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $276 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $143 |
| Gabapentin | 34 | $116 |
| Tramadol Hcl | 26 | $93 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Boise
- Kaitlin NearyBoise$867K
- Steven RoserBoise$102K
- Ryan KempBoise$8K
- Travis KempBoise$7K
- David ZarkouBoise$6K
- Scott BirdBoise$3K
- Boyd AndrewsBoise$2K
- Robert SwensenBoise$781
- Dan RobinsonBlackfoot$170K
- Kurt KinghornMeridian$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.